Clinical trial participants should have a say in new drug pricing
| 05-18-2017
Clinical trial participants should have a say in new drug pricing. Credit: ranys - PixabayPeople who volunteer to participate in clinical trials of new drugs provide a valuable service to pharmaceutical companies and to the rest of us. In return, I think that they should have a say in how much these drugs will cost when they hit the market. Not only would that honor their service, but it would also provide a patient-centered mechanism to lower the price of new drugs. …
Related Videos
Recommended
Popular
A rift in the retina may help repair the optic nerve 01-14-2021 
Designer cytokine makes paralyzed mice walk again 01-15-2021 
Rapid blood test identifies COVID-19 patients at high risk of… 01-15-2021 
Acute itching in eczema patients linked to environmental allergens 01-14-2021 
Stem cell infusions help repair COVID-19 damage in severe cases 01-05-2021